BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20728967)

  • 1. Body composition in childhood inflammatory bowel disease.
    Wiskin AE; Wootton SA; Hunt TM; Cornelius VR; Afzal NA; Jackson AA; Beattie RM
    Clin Nutr; 2011 Feb; 30(1):112-5. PubMed ID: 20728967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease.
    Sylvester FA; Leopold S; Lincoln M; Hyams JS; Griffiths AM; Lerer T
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):452-5. PubMed ID: 19249399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and early onset inflammatory bowel disease.
    Ceballos C
    Gastroenterol Nurs; 2008; 31(2):101-4; quiz 104-6. PubMed ID: 18391796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: Body composition in children with inflammatory bowel disease.
    Thangarajah D; Hyde MJ; Konteti VK; Santhakumaran S; Frost G; Fell JM
    Aliment Pharmacol Ther; 2015 Jul; 42(2):142-57. PubMed ID: 26043941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition in inflammatory bowel disease: an anthropometric study.
    Harries AD; Jones LA; Heatley RV; Rhodes J
    Hum Nutr Clin Nutr; 1982; 36(4):307-13. PubMed ID: 7141885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase.
    Rocha R; Santana GO; Almeida N; Lyra AC
    Br J Nutr; 2009 Mar; 101(5):676-9. PubMed ID: 18631418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation in inflammatory bowel disease.
    Kirschner BS; Voinchet O; Rosenberg IH
    Gastroenterology; 1978 Sep; 75(3):504-11. PubMed ID: 680509
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
    Kluge G; Borte M; Richter T; Kahn T; Borte G
    Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998-2000].
    Urne FU; Paerregaard A
    Ugeskr Laeger; 2002 Dec; 164(49):5810-4. PubMed ID: 12523226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease in childhood. Presentation and diagnosis.
    Krebs C; Nixon HH
    Z Kinderchir; 1983 Dec; 38(6):387-91. PubMed ID: 6666365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometry at the time of diagnosis in Danish children with inflammatory bowel disease.
    Paerregaard A; Uldall Urne F
    Acta Paediatr; 2005 Nov; 94(11):1682-3. PubMed ID: 16303711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
    Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
    Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of parenteral nutrition in the course of chronic inflammatory diseases of the intestine].
    de Oca J; Lera JM; Fakih A; Clemente JL; Goena L; Hernández JL
    Rev Esp Enferm Apar Dig; 1984 May; 65(5):419-25. PubMed ID: 6431560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition in patients with inflammatory bowel disease: a population-based study.
    Jahnsen J; Falch JA; Mowinckel P; Aadland E
    Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease.
    Wiskin AE; Wootton SA; Culliford DJ; Afzal NA; Jackson AA; Beattie RM
    Clin Nutr; 2009 Dec; 28(6):652-6. PubMed ID: 19515463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.